I was diagnosed with Stage 4 prostate cancer in November of 2008. After discussing the options with my family, I decided to try clinical trials instead of following the standard course of treatment. My first clinical trial combined 6 rounds of chemotherapy with the standard hormone replacement therapy (editors note – ADT). This trial was [...]
Darryl, the Malecare Executive Director, posted an organizational response to yesterday's New York Times Article on the newly approved advanced prostate cancer drugs and their economic impact. I thought that I would share his insightful post with everyone. "We can easily price commodities and drugs to whatever the market will bare, but how do we [...]
There has been a lot of publicity surrounding the $787 billion economic stimulus bill approved by Congress. One thing that the bill will do for the first time is provide substantial amounts of money for the federal government to compare the effectiveness of different treatments for the same illness. Researchers are scheduled to receive $1.1 [...]
